JPS6221765B2 - - Google Patents

Info

Publication number
JPS6221765B2
JPS6221765B2 JP51082846A JP8284676A JPS6221765B2 JP S6221765 B2 JPS6221765 B2 JP S6221765B2 JP 51082846 A JP51082846 A JP 51082846A JP 8284676 A JP8284676 A JP 8284676A JP S6221765 B2 JPS6221765 B2 JP S6221765B2
Authority
JP
Japan
Prior art keywords
escin
amorphous
ray
solution
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP51082846A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5234915A (en
Inventor
Maadausu Rorufu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Madaus Holding GmbH
Original Assignee
Dr Madaus GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Madaus GmbH and Co filed Critical Dr Madaus GmbH and Co
Publication of JPS5234915A publication Critical patent/JPS5234915A/ja
Publication of JPS6221765B2 publication Critical patent/JPS6221765B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
JP51082846A 1975-07-11 1976-07-12 Xxray diffraction amorphous escin* its preparation and ittcontaining antitransudation agent Granted JPS5234915A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2530953A DE2530953C2 (de) 1975-07-11 1975-07-11 Verfahren zur Herstellung von röntgenamorphem Aescin, nach diesem Verfahren erhältliches röntgenamorphes Aescin und dieses enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
JPS5234915A JPS5234915A (en) 1977-03-17
JPS6221765B2 true JPS6221765B2 (fr) 1987-05-14

Family

ID=5951225

Family Applications (2)

Application Number Title Priority Date Filing Date
JP51082846A Granted JPS5234915A (en) 1975-07-11 1976-07-12 Xxray diffraction amorphous escin* its preparation and ittcontaining antitransudation agent
JP61304058A Granted JPS6366127A (ja) 1975-07-11 1986-12-22 Ｘ線回折無定形エスシンを含有する抗滲出剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP61304058A Granted JPS6366127A (ja) 1975-07-11 1986-12-22 Ｘ線回折無定形エスシンを含有する抗滲出剤

Country Status (20)

Country Link
JP (2) JPS5234915A (fr)
AU (1) AU510463B2 (fr)
BE (1) BE844053A (fr)
BG (1) BG27379A3 (fr)
CA (1) CA1064903A (fr)
CS (1) CS208184B2 (fr)
DE (1) DE2530953C2 (fr)
ES (1) ES449748A1 (fr)
FI (1) FI62099C (fr)
FR (1) FR2316961A1 (fr)
GB (1) GB1550845A (fr)
HK (1) HK33681A (fr)
HU (1) HU174603B (fr)
PH (1) PH13989A (fr)
PL (1) PL99028B1 (fr)
PT (1) PT65302B (fr)
RO (1) RO70354A (fr)
SU (1) SU786857A3 (fr)
YU (1) YU41812B (fr)
ZA (1) ZA764065B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1252201B (it) * 1991-12-12 1995-06-05 Dompe Farmaceutici Spa S-carbossimetilcisteina sale di lisina monoidrato e procedimento per la sua preparazione.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE302543C (fr) *
NL301747A (fr) * 1962-12-14
YU37063B (en) * 1971-12-06 1984-08-31 Lek Tovarna Farmacevtskih Process for preparing x-ray amorphous water-sulubleascin
DE2357226A1 (de) * 1973-11-16 1975-05-28 Merck Patent Gmbh Verfahren zur herstellung von wasserloeslichem beta-aescin

Also Published As

Publication number Publication date
SU786857A3 (ru) 1980-12-07
BG27379A3 (bg) 1979-10-12
YU41812B (en) 1988-02-29
PH13989A (en) 1980-11-28
FI62099C (fi) 1982-11-10
AU510463B2 (en) 1980-06-26
HK33681A (en) 1981-07-24
BE844053A (fr) 1977-01-12
DE2530953A1 (de) 1977-01-27
JPS5234915A (en) 1977-03-17
FI761895A7 (fr) 1977-01-12
CA1064903A (fr) 1979-10-23
PT65302B (de) 1977-12-13
PT65302A (de) 1976-07-01
ZA764065B (en) 1977-07-27
AU1572976A (en) 1978-01-12
JPH0336808B2 (fr) 1991-06-03
FR2316961A1 (fr) 1977-02-04
ES449748A1 (es) 1977-08-16
GB1550845A (en) 1979-08-22
CS208184B2 (en) 1981-08-31
HU174603B (hu) 1980-02-28
FR2316961B1 (fr) 1984-04-20
PL99028B1 (pl) 1978-06-30
FI62099B (fi) 1982-07-30
DE2530953C3 (de) 1994-07-07
RO70354A (fr) 1982-03-24
DE2530953C2 (de) 1994-07-07
JPS6366127A (ja) 1988-03-24
YU167076A (en) 1983-06-30

Similar Documents

Publication Publication Date Title
CA1040532A (fr) Procede de preparation de produits pharmaceutiques solides contenant du bismuth
IT8224368A1 (it) Medicamenti ad alto grado di solubilità e procedimento per il loro ottenimento
IL42764A (en) S-adenosyl-2-methionine tri-p-toluene sulfonate,its preparation and therapeutic compositions containing it
ME01520B (me) KRISTAL JEDINJENJA 1,2-DIHIDROPIRIDINA l METOD ZA NJEGOVU PROIZVODNJU
CN110075000A (zh) 一种羟基酪醇包合物及其制备方法和用途
US2950309A (en) Amphetamine tannate
JPS58185578A (ja) 新規結晶形の（＋）―カテキン１水和物，その製造方法及びそれを含有する固形製剤
JPS6221765B2 (fr)
TAKAHASHI et al. Interaction of several nonsteroidal antiinflammatory drugs with pectin in aqueous solution and in solid state
Portoghese et al. Relative hydrolytic rates of certain alkyl (b) dl-α-(2-piperidyl)-phenylacetates
NO304730B1 (no) FremgangsmÕte for fremstilling av nimesulide og cyklodekstrinkomplekser
Xia et al. Synthesis and characterization of a novel soluble neohesperidin-copper (II) complex using Ion-exchange resin column
FI71314C (fi) Foerfarande foer framstaellning av en terapeutiskt anvaendbar beta-(4,5-difenyloxazol-2-yl) propionsyrakalciumsalt
Minzanova et al. Complexes of pectin polysaccharide with acetylsalicylic acid.
RU95115702A (ru) Анальгезирующее жаропонижающее лекарственное средство и способ его получения
CN108752334A (zh) 一种黄藤素-对苯二甲酸药物共晶及其制备方法
KR820002108B1 (ko) 수용성 산성 사포닌의 제조 방법
NO762064L (fr)
RU2070034C1 (ru) Противовоспалительный состав пролонгированного действия на основе диклофенака натрия и способ его получения
JPH0348897B2 (fr)
Daniels et al. The electrochromic behaviour of lanthanide bisphthalocyanines: The acid-base nature of the mechanism
JPH05310686A (ja) Ｓ−カルボキシメチルシステインリジンモノハイドレートおよびその調製方法
SU501762A1 (ru) Способ получени препарата низкомолекул рного поливинилпирролидона
JPH0141606B2 (fr)
MXPA00007921A (en) Novel galenic formulations of meloxicam for oral administration